ID   BIU-87/ADMR
AC   CVCL_6882
SY   BIU-87/ADM; BIU-87/DOX
DR   Wikidata; Q54796898
RX   PubMed=9594332;
RX   PubMed=23618585;
RX   PubMed=30967374;
CC   Problematic cell line: Misidentified/contaminated. Parent cell line (BIU-87) seems to be contaminated by non-human cells.
CC   Doubling time: 48 hours (PubMed=9594332); 31.58 +- 0.37 hours (PubMed=30967374).
CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
OX   NCBI_TaxID=32644; ! Unidentified (Unknown organism)
HI   CVCL_6881 ! BIU-87
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
RX   PubMed=9594332; DOI=10.5555/cmj.0366-6999.110.03.p167.01;
RA   Guo H.-Q., Lu G.-C., Xiong X.-L., Dong J.-H., Liu S.-C., Zao S.-Y.;
RT   "Establishment of doxorubicin-resistant human bladder cancer cell line
RT   (BUI-87/ADMR) and its mechanism of multidrug resistance.";
RL   Chin. Med. J. 110:167-172(1997).
//
RX   PubMed=23618585; DOI=10.1016/j.juro.2013.04.053;
RA   Zhou H.-L., Zheng Y.-J., Cheng X.-Z., Lv Y.-S., Gao R., Mao H.-P.,
RA   Chen Q.;
RT   "Intercellular transfer of P-glycoprotein from the drug resistant
RT   human bladder cancer cell line BIU-87 does not require cell-to-cell
RT   contact.";
RL   J. Urol. 190:1069-1075(2013).
//
RX   PubMed=30967374; DOI=10.1242/bio.041889;
RA   Cheng X.-Z., Zhou H.-L., Tang S.-X., Jiang T., Chen Q., Gao R.,
RA   Ding Y.-L.;
RT   "Intercellular transfer of P-glycoprotein mediates the formation of
RT   stable multi-drug resistance in human bladder cancer BIU-87 cells.";
RL   Biol. Open 8:bio041889.1-bio041889.6(2019).
//